CRP and cancer: The Glasgow Prognostic Score (GPS), which combines C-reactive protein and albumin levels that reflects the systemic inflammation status and the nutrition status of the patient, respectively, has been reported to be a reliable tool for assessing the status of cancer cachexia [11,12].